Lockheed Martin enters the final stretch before its July 21 Q2 earnings with the stock recovering from last week's sector selloff — and a fresh Citigroup upgrade landing on the same day.
The most significant development this week is a rating change from Citi. Analyst John Godyn upgraded LMT to Buy from Neutral on July 1, lifting his target to $582 from $571. That reverses the same analyst's target cut in May, when he trimmed from $675 to $571. The upgrade is notable in its timing — coming less than three weeks before earnings — but it's also worth keeping in perspective: the new target of $582 still sits well below the broader consensus mean of $617. Morgan Stanley holds at Equal-Weight with a $653 target, and most of the Street remains in hold territory, with 13 holds against just 5 buys. The direction of analyst travel since April has generally been downward target revisions following Q1's 7.6% single-day drop, so Citi's move is a genuine outlier rather than a trend reversal.
The price recovery is real but modest. Shares closed at $509.46 on June 30 — up 1.5% on the day and 1.1% on the week — clawing back ground after last week's sector-wide drop that had taken the stock to $503. Closest peer was roughly flat on the week at -0.8%, while added 1.8% and gained 1.1%. and both gave back ground, down 1.3% and 1.1% respectively. The rebound in LMT looks broadly in line with peers rather than company-specific.
Options positioning has eased slightly but remains more defensive than usual. The put/call ratio is running at 0.72, still about 1.2 standard deviations above its 20-day average of 0.64 and meaningfully higher than the 0.56 level seen two weeks ago. The ratio has held in a tight range between 0.71 and 0.73 for the past week — suggesting defensive positioning has stabilized rather than escalating or unwinding. The 52-week high on the PCR is 0.86, so this is not extreme, but it reflects a market that has been buying downside protection and hasn't rushed to unwind it despite the stock's partial recovery.
Short interest and the borrow market tell the same story they did a week ago, and that hasn't changed materially. Short interest holds at 1.4% of free float — up 24% over the past month in share terms, but the absolute level remains low for a name this size. Availability is at the maximum reading in the data, meaning the lending pool is essentially unlimited relative to current demand. Cost to borrow ticked up to 0.42% from a trough near 0.31% mid-week, but that remains well within normal territory for a large-cap defense stock. There is no squeeze pressure, no borrow stress, and no sign that the short interest build reflects a high-conviction directional trade. The balance of evidence still points to hedging ahead of earnings rather than outright bearish positioning.
The factor profile adds a nuanced layer. The dividend score ranks in the 97th percentile — a genuine strength for income-oriented holders. Forward EPS growth ranks at the 79th percentile on a 12-month basis. But near-term earnings momentum is weaker: the 30-day EPS momentum rank is just 28 and the 90-day rank sits at 35 — both below the midpoint. The short score of 30.7 has ticked up from around 29.3 a week ago, a modest move that reflects the short interest build without yet crossing into territory that would signal elevated pressure. The Q2 earnings print on July 21 will be the first real test of whether the forward EPS growth thesis holds after Q1's miss-driven selloff.
With Citi's upgrade on the tape and the stock stabilising, the question going into July 21 is whether the Street's cautious consensus — 13 holds, modest targets, muted EPS momentum — gets revised or reinforced by Q2 results and any update to full-year guidance.
See the live data behind this article on ORTEX.
Open LMT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
